Skip to main content
. 1999 Oct;48(4):564–572. doi: 10.1046/j.1365-2125.1999.00053.x

Figure 4.

Figure 4

Steady-state serum concentration-time profiles of N-dealkylated tolterodine in the absence (a) and presence (b) of ketoconazole, 200 mg once daily, after 1 mg twice-daily administration of tolterodine l-tartrate to subjects with deficient CYP2D6 activity.